Stock screenerAll disclosures →
EDGAR →
WRBY
Conviction 37HealthcareScan · Mon, Aug 10, 2026WRBY$26.43-0.11%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 2.93M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price26.43
Change-0.11%
Gap-1.46%
Rel volume0.62×
Avg volume2.91M
Avg $ vol77.42M
SMA 2026.45
SMA 5026.55
SMA 20024.22
Price vs 50-0.45%
Price vs 200+9.11%
MA stackmixed
50/200 cross—
Supertrendup · 24.65
RSI (14)48
MACD hist0.08
MACD crossbull · 5d
Stoch %K / %D39 / 42
ADX (14)13
+DI / −DI25 / 24
RSI divergence—
MACD divergence—
ATR %+6.90%
ADR %5.99%
52w high30.34
52w low16.49
From 52w high-12.89%
Above 52w low+60.28%
New 52w highNo
SqueezeOff
Bollinger width23.95%
%B0.50
Donchian pos39.43%
Donchian high30.93
Donchian low23.50
AVWAP (52w high)25.51
vs AVWAP high+3.61%
AVWAP (52w low)24.60
vs AVWAP low+7.44%
OBV trendDown
Chaikin MF (20)0.14
Today vs 20d0.62×
Avg vol (14d)2.93M
Avg vol (20d)2.91M
Avg $ vol (20d)77.42M
Market cap2.99B
RS 3m (vs SPY)-8.42%
RS 6m (vs SPY)-2.98%
RS line new highNo
Trend template6/8
Technical rank50.4
1 week-6.54%
1 month-9.02%
3 months-10.56%
6 months+3.57%
1 year+12.56%
YTD+16.84%
P/E1822.93
P/B7.63
P/S3.43
P/FCF68.40
EPS0.0100
Div yield—
ROE0.42%
ROA0.21%
Debt/Eq—
Current2.27
EV/EBITDA60.05
Gross margin53.97%
Net margin0.19%
Rev growth13.04%
EPS growth108.05%
Price target30.00
Target upside13.51%
Analyst ratingBuy
Institutional120.93%
Ent. value2.7B
Revenue235.51M
Net income4.64M
Gross profit136.46M
Free cash flow43.74M
IndustryOPHTHALMIC GOODS
ExchangeNYSE
Shares out107.09M
Employees4.04K
ListedWed, Sep 29, 2021
Free float100.8M
Float %94.4%
Short interest17.86M
Days to cover7.6d
Short volume69.7%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.05 vs $0.05
Last surprise0.0% beat
Setup gradeD
Conviction37 / 100
Pattern quality—
Tech rank50.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance30.91
Support23.80
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in WRBY
No recent disclosed trades by Congress in WRBY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in WRBY · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Blumenthal Neil Harris Co-Chief Executive Officer · Class A Common Stock · 2026-07-06 | Convert | 9.2K | — | 2026-07-06 | 2026-07-08 |
Blumenthal Neil Harris Co-Chief Executive Officer · Class A Common Stock · 2026-07-06 | Sell | 9.2K | $276K | 2026-07-06 | 2026-07-08 |
Blumenthal Neil Harris Co-Chief Executive Officer · Class B Common Stock · 2026-07-06 | Convert | 9.2K | — | 2026-07-06 | 2026-07-08 |
Gilboa David Abraham Co-Chief Executive Officer · Class A Common Stock · 2026-07-06 | Convert | 54.35K | — | 2026-07-06 | 2026-07-08 |
Gilboa David Abraham Co-Chief Executive Officer · Class A Common Stock · 2026-07-06 | Sell | 54.35K | $1.6M | 2026-07-06 | 2026-07-08 |
Gilboa David Abraham Co-Chief Executive Officer · Stock Option (Right to Buy) · 2026-07-06 | Exercise | 54.35K | — | 2026-07-06 | 2026-07-08 |
Gilboa David Abraham Co-Chief Executive Officer · Class B Common Stock · 2026-07-06 | Exercise | 54.35K | $208K | 2026-07-06 | 2026-07-08 |
Gilboa David Abraham Co-Chief Executive Officer · Class B Common Stock · 2026-07-06 | Convert | 54.35K | — | 2026-07-06 | 2026-07-08 |
Briggs Teresa Director · Class A Common Stock · 2026-06-16 | Sell | 3.09K | $79K | 2026-06-16 | 2026-06-18 |
Briggs Teresa Director · Class A Common Stock · 2026-06-16 | Sell | 1.91K | $51K | 2026-06-16 | 2026-06-18 |
SEC filings
EDGAR filings in WRBY · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.